Advertisement

Document › Details
Shimadzu Corporation. (7/6/15). "Press Release: EDX-7000/8000 Energy Dispersive X-Ray Fluorescence Spectrometers Now Compliant with the US FDA 21 CFR Part 11 Electronic Records, Electronic Signatures".
![]() |
Region | United States (USA) |
![]() |
Organisation | Shimadzu (Group) |
Organisation 2 | FDA (US Food and Drug Administration) | |
Group | United States (govt) | |
![]() |
Product | EDX-LE energy dispersive X-ray fluorescence spetrometer |
Product 2 | LabSolutions CS CDS | |
Shimadzu announces its EDX-7000/8000 energy dispersive X-ray fluorescence spectrometers are now compliant with the 21 CFR Part 11 Electronic Records; Electronic Signatures, which is designated by the U.S. Food and Drug Administration (FDA).
It is expected that an application of impurity inspection for drugs by X-ray fluorescence analysis . With this trend, the market for energy dispersive X-ray fluorescence spectrometers will expand in the pharmaceutical industry. Making the EDX-7000 and EDX-8000 compliant with the U.S. regulation for electronic records and electronic signatures addresses this new requirement. Shimadzu plans to actively market these instruments in the pharmaceutical industry, with sales targets of at least 20 units of these two models in FY 2015 and at least 40 units in FY 2016 and after.
The U.S. FDA put into effect 21 CFR Part 11 in 1997. This regulation defines the criteria under which electronic records and electronic signatures are considered to be equivalent to records and signatures on paper. It applies to pharmaceutical and food companies that perform business activities in the U.S., companies that supply products or raw materials to these companies, including exporting, and laboratories that receive contracted analysis from these companies. The regulation defines that records and signatures must not be altered and changes need to be recorded to make the electronic records and signatures trustworthy.
Features of EDX-7000/8000 in measurement of pharmaceutical products
These spectrometers analyze residues such as residual metal catalysts, hazardous metals, and metal impurities contained in active pharmaceutical ingredients easily and non-destructively without requiring any pretreatment. They allow users to start analysis of a powder, solid, or liquid sample by simply placing the sample in the special assembled container and setting the container in the instrument. As compared to chemical analysis procedures that require significant work and time, the EDX-7000/8000 offers simplified operation in any pharmaceutical production process.
Shimadzu also offers the LabSolutions CS network system for data management of a number of analytical instruments. LabSolutions CS enables management of analytical data obtained by all compatible instruments, including the EDX series instruments, in a database on the server computer. Use of the network system enables integrated data management where data can be loaded on any computer on the network.
For more details, visit
http://www.shimadzu.com/an/elemental/edxrf/edx7000_8000/feature9.html
Record changed: 2019-06-09 |
Advertisement
![Picture [iito] No Tracking 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-tracking.jpg)
More documents for Shimadzu (Group)
- [1] Shimadzu Corporation. (1/11/19). "Press Release: New Probe Electrospray Ionization Mass Spectrometer Enables Quick Detection of Pharmacological Agents and Metabolites"....
- [2] Shimadzu Corporation. (1/11/19). "Press Release: Shimadzu’s New Preparative Purification LC System Provides High Efficiency, Saves Space, and Enables Multi-Sample Processing"....
- [3] Shimadzu Corporation. (1/9/19). "Press Release: Automating the Analysis of Biological Samples to Provide a Revolutionary Workflow. Shimadzu’s New CLAM-2030 Fully Automated Preparation Module for LCMS"....
- [4] Shimadzu Corporation. (9/5/18). "Press Release: Shimadzu’s New Three Gas Chromatograph Mass Spectrometer Models—GCMS NX Series Achieving World Class Performance and Reforming Working Practices"....
- [5] Shimadzu Corporation. (8/22/18). "Press Release: New ImageReveal MS Mass Spectrometry Imaging Data Analysis Software Simplifies Analysis of Large Quantities of Data"....
- [6] Shimadzu Corporation. (8/7/18). "Press Release: Operating Results and Financial Position (for the Three Months Ended June 30, 2018)". Kyoto....
- [7] Shimadzu Corporation. (7/25/18). "Presentation: Outline & Strategy of Mass Spectrometry Business – Mass Spectrometer Business Presentation Materials (Hiroto Itoi) [Date on Presentation Slide July 3, 2018]"....
- [8] Shimadzu Scientific Instruments, Inc.. (6/19/18). "Press Release: Shimadzu Releases C2MAP-2000 Automated Pretreatment Module for Cell Culture Media Analysis"....
- [9] Premier Biosoft International. (6/4/18). "Press Release: Shimadzu Corporation Collaborates with Premier Biosoft to Launch the LCMS-9030 Q-TOF Platform for Comprehensive Lipid and Glycan Analysis". Palo Alto, CA....
- [10] Shimadzu Scientific Instruments, Inc.. (6/1/18). "Press Release: Shimadzu Enhances Its Mass Spectrometry Platform with the Launch of a New Q-TOF System"....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
![Picture [iito] Fighting Customers 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-fighting-customers.jpg)
» top